Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Cytokine. 2016 May 25;84:37–46. doi: 10.1016/j.cyto.2016.05.017

Fig. 2.

Fig. 2

IL-2, IL-4, IFN-γ, or TNF-α promotes B-cell viability/survival. Raji cells were treated with 0–100 ng/ml of IL-2, IL-4, IFN-γ, or TNF-α for 48 h, respectively. (A) Cell viability was monitored by MTS assay. (B) Relative number of live cells was estimated by trypan blue exclusion assay. Results are presented as mean ± S.E. (n = 5). *p<0.05, **p<0.01, difference with control group.